PRECISION OPTICS CORPORATION, INC. (POCI) Shareholder Equity
- 2026-03-31: Common Stock, Value, IssuedUSD $109.30K; Additional Paid in CapitalUSD $80.49M; Retained Earnings (Accumulated Deficit)USD $-60.50M; Stockholders' Equity Attributable to ParentUSD $20.11M.
- 2025-12-31: Common Stock, Value, IssuedUSD $77.20K; Additional Paid in CapitalUSD $69.64M; Retained Earnings (Accumulated Deficit)USD $-60.39M; Stockholders' Equity Attributable to ParentUSD $9.33M.
- 2025-09-30: Common Stock, Value, IssuedUSD $77.15K; Additional Paid in CapitalUSD $69.45M; Retained Earnings (Accumulated Deficit)USD $-58.61M; Stockholders' Equity Attributable to ParentUSD $10.92M.
- 2025-06-30: Common Stock, Value, IssuedUSD $77.15K; Additional Paid in CapitalUSD $69.15M; Retained Earnings (Accumulated Deficit)USD $-56.97M; Stockholders' Equity Attributable to ParentUSD $12.26M.
PRECISION OPTICS CORPORATION, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $109.30K | $80.49M | $-60.50M | $20.11M | 3 month · $247.53K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $77.20K | $69.64M | $-60.39M | $9.33M | 3 month · $162.08K | (m) | (m) | (m) | (m) |
| 2025-09-30 | $77.15K | $69.45M | $-58.61M | $10.92M | 3 month · $301.64K | (m) | (m) | (m) | (m) |
| 2025-06-30 | $77.15K | $69.15M | $-56.97M | $12.26M | 12 month · $1.46M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $76.66K | $68.67M | $-55.57M | $13.18M | 3 month · $592.96K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $63.55K | $62.88M | $-53.47M | $9.48M | 3 month · $278.21K | (m) | (m) | (m) | (m) |
| 2024-09-30 | $63.50K | $62.58M | $-52.50M | $10.14M | 3 month · $149.36K | (m) | (m) | (m) | (m) |
| 2024-06-30 | $60.74K | $61.20M | $-51.19M | $10.07M | 12 month · $959.78K | (m) | (m) | (m) | (m) |
| 2024-03-31 | $60.69K | $60.98M | $-49.78M | $11.26M | 3 month · $258.21K | (m) | (m) | (m) | (m) |
| 2023-12-31 | $60.67K | $60.72M | $-49.46M | $11.32M | 3 month · $382.43K | (m) | (m) | (m) | (m) |
| 2023-09-30 | $60.66K | $60.33M | $-48.70M | $11.69M | 3 month · $108.75K | (m) | (m) | (m) | (m) |
| 2023-06-30 | $60.66K | $60.22M | $-48.24M | $12.05M | 12 month · $919.03K | (m) | (m) | (m) | (m) |
| 2023-03-31 | $56.41K | $57.78M | $-48.14M | $9.70M | 3 month · $450.01K | (m) | (m) | (m) | (m) |
| 2022-12-31 | $56.38K | $57.33M | $-47.53M | $9.64M | 3 month · $244.79K | (m) | (m) | (m) | (m) |
| 2022-09-30 | $169.15K | $56.97M | $-48.17M | $8.89M | 3 month · $74.99K | (m) | (m) | (m) | (m) |
| 2022-06-30 | $56.38K | $57.01M | $-48.09M | $8.97M | 12 month · $895.49K | (m) | (m) | (m) | (m) |
| 2022-03-31 | $168.88K | $56.72M | $-48.36M | $8.53M | 3 month · $231.12K | (m) | (m) | (m) | (m) |
| 2021-12-31 | $167.47K | $57.27M | $-48.25M | $9.19M | 3 month · $330.45K | (m) | (m) | (m) | (m) |
| 2021-09-30 | $132.82K | $50.61M | $-47.74M | $4.03M | 3 month · $160.07K | (m) | (m) | (m) | (m) |
| 2021-06-30 | $132.82K | $50.46M | $-47.17M | $3.43M | 12 month · $733.93K | (m) | (m) | (m) | (m) |
| 2021-03-31 | $132.64K | $50.04M | $-46.72M | $3.45M | 3 month · $86.03K | (m) | (m) | (m) | (m) |
| 2020-12-31 | $131.92K | $49.93M | $-47.28M | $2.79M | 3 month · $157.08K | (m) | (m) | (m) | (m) |
| 2020-09-30 | $131.92K | $49.77M | $-47.06M | $2.84M | 3 month · $71.15K | (m) | (m) | (m) | (m) |
| 2020-06-30 | $131.92K | $49.70M | $-47.06M | $2.77M | 12 month · $502.35K | (m) | (m) | (m) | (m) |
| 2020-03-31 | $129.92K | $49.39M | $-46.74M | $2.78M | 3 month · $75.57K | (m) | 3 month · $75.57K | (m) | (m) |
| 2019-12-31 | $128.80K | $49.31M | $-46.27M | $3.17M | 3 month · $274.71K | (m) | 3 month · $274.71K | (m) | (m) |
| 2019-09-30 | $128.69K | $49.04M | $-45.72M | $3.45M | 3 month · $76.50K | (m) | 3 month · $76.50K | (m) | (m) |
| 2019-06-30 | $120.71K | $48.89M | $-45.64M | $3.38M | 12 month · $263.33K | (m) | (m) | (m) | (m) |
| 2019-03-31 | $120.38K | $47.84M | $-45.53M | $2.43M | 3 month · $2.89K | (m) | 3 month · $2.89K | (m) | (m) |
| 2018-12-31 | $118.97K | $47.80M | $-45.45M | $2.47M | 3 month · $10.23K | (m) | 3 month · $10.23K | (m) | (m) |
| 2018-09-30 | $102.97K | $45.83M | $-45.32M | $607.74K | 3 month · $342.98K | (m) | 3 month · $342.98K | (m) | (m) |
| 2018-06-30 | $101.97K | $45.48M | $-45.02M | $564.04K | 12 month · $52.34K | (m) | (m) | (m) | (m) |
| 2018-03-31 | $100.95K | $45.42M | $-45.04M | $485.70K | 3 month · $8.97K | (m) | (m) | (m) | (m) |
| 2017-12-31 | $100.95K | $45.41M | $-44.76M | $756.00K | 3 month · $6.97K | (m) | (m) | (m) | (m) |
| 2017-09-30 | $94.28K | $45.41M | $-44.70M | $802.69K | 3 month · $26.06K | (m) | (m) | (m) | (m) |
| 2017-06-30 | $88.73K | $45.14M | $-44.67M | $558.38K | 12 month · $201.61K | (m) | (m) | (m) | (m) |
| 2017-03-31 | $88.73K | $45.09M | $-44.43M | $749.11K | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $88.73K | $45.04M | $-44.27M | $862.10K | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $75.40K | $44.24M | $-43.96M | $354.67K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $75.40K | $44.18M | $-43.66M | $587.17K | 12 month · $241.39K | (m) | (m) | (m) | (m) |
| 2016-03-31 | $75.40K | $44.13M | $-43.51M | $689.38K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $74.35K | $44.05M | $-43.29M | $829.66K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $63.90K | $43.33M | $-43.01M | $385.32K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $63.90K | $43.23M | $-42.63M | $666.89K | 12 month · $125.67K | (m) | (m) | (m) | (m) |
| 2015-03-31 | $63.45K | $43.12M | $-42.27M | $914.36K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $62.63K | $43.09M | $-42.07M | $1.08M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $62.63K | $43.08M | $-41.75M | $1.39M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $44.55K | $42.15M | $-41.45M | $740.58K | 12 month · $141.03K | (m) | (m) | 12 month · $50.00K | (m) |
| 2014-03-31 | $44.55K | $42.06M | $-41.13M | $975.50K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $44.55K | $42.02M | $-40.75M | $1.31M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $44.55K | $41.99M | $-40.50M | $1.53M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $44.55K | $41.96M | $-40.29M | $1.71M | 12 month · $108.42K | (m) | (m) | (m) | (m) |
| 2013-03-31 | $44.55K | $41.92M | $-40.12M | $1.85M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $40.79K | $41.24M | $-39.77M | $1.52M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $40.29K | $41.22M | $-38.86M | $2.40M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $12.51K | $39.01M | $-38.50M | $519.33K | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $12.45K | $38.98M | $-38.28M | $713.60K | (m) | (m) | (m) | (m) | 47.40K |
| 2011-12-31 | $12.45K | $38.95M | $-37.79M | $1.17M | (m) | (m) | (m) | (m) | 47.40K |
| 2011-09-30 | $9.71K | $38.27M | $-37.46M | $815.81K | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $9.71K | $38.26M | $-39.46M | $-1.19M | (m) | 12 month · $-474.00 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | 9 month · $-474.00 | (m) | (m) | 47.40K |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | 6 month · $-474.00 | (m) | (m) | 47.40K |
| 2010-06-30 | (m) | (m) | (m) | $-164.25K | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |